Leslie R Harrold (Leslie L Harrold)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Rheumatoid Arthritis

Randomized Controlled Trial

Disease Activity

Top Venues

Arthritis care & research

Rheumatology and therapy

The Journal of rheumatology

Advances in rheumatology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Leslie R Harrold, Keith Wittstock, Sheila Kelly, Xue Han, Joe Zhuo, Amy Schrader, Nicole Middaugh, Page C Moore, Vadim Khaychuk
Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive. Advances in rheumatology (London, England) 64 (1) (2024)
Leslie R Harrold, Keith Wittstock, Sheila Kelly, Xue Han, Joe Zhuo, Amy Schrader, Nicole Middaugh, Page C Moore, Vadim Khaychuk
Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive. Advances in rheumatology (London, England) 64 (1) (2024)
Leslie R Harrold, Keith Wittstock, Sheila Kelly, Xue Han, Joe Zhuo, Amy Schrader, Nicole Middaugh, Page C Moore, Vadim Khaychuk
Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive. Advances in rheumatology (London, England) 64 (1) (2024)
Leslie R Harrold, Patrick Zueger, W Benjamin Nowell, Taylor Blachley, Amy Schrader, Paul R Lakin, David Curtis, Laura Stradford, Shilpa Venkatachalam, Namita Tundia, Pankaj A Patel
A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis. Rheumatology and therapy (2023)
Leslie R Harrold, Keith Wittstock, Sheila Kelly, Xue Han, Ying Shan, Lin Guo, Page C Moore, Vadim Khaychuk
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP. Rheumatology and therapy (2023)
Leslie R Harrold, Joshua Bryson, Thomas Lehman, Joe Zhuo, Sheng Gao, Xue Han, Amy Schrader, Sabrina Rebello, Dimitrios A Pappas, Tanya Sommers, Joel M Kremer
Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA. Rheumatology and therapy 8 (2) (2021)
Joel M Kremer, George Reed, Dimitrios A Pappas, Kevin Kane, Vivi L Feathers, Michael E Weinblatt, Nancy A Shadick, Jeffrey D Greenberg, Leslie R Harrold
Dr. Kremer et al reply. The Journal of rheumatology (2021)
Jeffrey R Curtis, J Lynn Palmer, George W Reed, Jeffrey Greenberg, Dimitrios A Pappas, Leslie R Harrold, Joel M Kremer
Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis. Arthritis care & research 73 (8) (2021)
Philip S Helliwell, Mei Liu, Meghan E Glynn, Kelechi Emeanuru, Leslie R Harrold, Sven Richter, Benoit Guerette, Philip J Mease
Descriptive Comparisons of the Effect of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: The Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results. The Journal of rheumatology 48 (5) (2020)
Leslie R Harrold, Ying Shan, Sabrina Rebello, Neil Kramer, Sean E Connolly, Evo Alemao, Sheila Kelly, Joel M Kremer, Elliot D Rosenstein
Prevalence of Sjögren's syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry. Clinical rheumatology 39 (6) (2020)
Leslie R Harrold, Ying Shan, Sabrina Rebello, Neil Kramer, Sean E Connolly, Evo Alemao, Sheila Kelly, Joel M Kremer, Elliot D Rosenstein
Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry. Rheumatology international 40 (8) (2020)
Daniel H Solomon, Bing Lu, Zhi Yu, Cassandra Corrigan, Leslie R Harrold, Josef S Smolen, Liana Fraenkel, Jeffrey N Katz, Elena Losina
Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical Trial. Arthritis care & research 70 (10) (2019)
Philip S Helliwell, J Lynn Palmer, Jeffrey Greenberg, Jeffrey R Curtis, Leslie R Harrold, Daniel H Solomon, Arthur Kavanaugh, Joel M Kremer, Philip J Mease
Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor. The Journal of rheumatology 46 (5) (2019)
Daniel H Solomon, Zhi Yu, Jeffrey N Katz, Asaf Bitton, Cassandra Corrigan, Liana Fraenkel, Leslie R Harrold, Josef S Smolen, Elena Losina, Bing Lu
Adverse Events and Resource Use Before and After Treat-to-Target in Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial. Arthritis care & research 71 (9) (2019)
Zhi Yu, Bing Lu, Jenifer Agosti, Asaf Bitton, Cassandra Corrigan, Liana Fraenkel, Leslie R Harrold, Elena Losina, Jeffrey N Katz, Daniel H Solomon
Implementation of Treat-to-Target for Rheumatoid Arthritis in the US: Analysis of Baseline Data From a Randomized Controlled Trial. Arthritis care & research 70 (5) (2018)
Daniel H Solomon, Elena Losina, Bing Lu, Agnes Zak, Cassandra Corrigan, Sara B Lee, Jenifer Agosti, Asaf Bitton, Leslie R Harrold, Theodore Pincus, Helga Radner, Zhi Yu, Josef S Smolen, Liana Fraenkel, Jeffrey N Katz
Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.) 69 (7) (2017)